Welcome to LookChem.com Sign In|Join Free
  • or
4-(4-CYANOBENZYL)-1,2,4-TRIAZOLE is an organic compound that serves as a crucial intermediate in the synthesis of Letrozole (L330100), a medication used for treating breast cancer.

112809-27-5

Post Buying Request

112809-27-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

112809-27-5 Usage

Uses

Used in Pharmaceutical Industry:
4-(4-CYANOBENZYL)-1,2,4-TRIAZOLE is used as an intermediate in the synthesis of Letrozole, an oral, non-steroidal, aromatase inhibitor for treating breast cancer as a result of hormone response after surgery.

Check Digit Verification of cas no

The CAS Registry Mumber 112809-27-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,2,8,0 and 9 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 112809-27:
(8*1)+(7*1)+(6*2)+(5*8)+(4*0)+(3*9)+(2*2)+(1*7)=105
105 % 10 = 5
So 112809-27-5 is a valid CAS Registry Number.
InChI:InChI=1/C10H8N4/c11-5-9-1-3-10(4-2-9)6-14-7-12-13-8-14/h1-4,7-8H,6H2

112809-27-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-((4H-1,2,4-Triazol-4-yl)methyl)benzonitrile

1.2 Other means of identification

Product number -
Other names 4-(1,2,4-triazol-4-ylmethyl)benzonitrile

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:112809-27-5 SDS

112809-27-5Relevant academic research and scientific papers

Taming Ambident Triazole Anions: Regioselective Ion Pairing Catalyzes Direct N-Alkylation with Atypical Regioselectivity

Dale, Harvey J.A.,Hodges, George R.,Lloyd-Jones, Guy C.

, p. 7181 - 7193 (2019/05/10)

Controlling the regioselectivity of ambident nucleophiles toward alkylating agents is a fundamental problem in heterocyclic chemistry. Unsubstituted triazoles are particularly challenging, often requiring inefficient stepwise protection-deprotection strategies and prefunctionalization protocols. Herein we report on the alkylation of archetypal ambident 1,2,4-triazole, 1,2,3-triazole, and their anions, analyzed by in situ 1H/19F NMR, kinetic modeling, diffusion-ordered NMR spectroscopy, X-ray crystallography, highly correlated coupled-cluster computations [CCSD(T)-F12, DF-LCCSD(T)-F12, DLPNO-CCSD(T)], and Marcus theory. The resulting mechanistic insights allow design of an organocatalytic methodology for ambident control in the direct N-alkylation of unsubstituted triazole anions. Amidinium and guanidinium receptors are shown to act as strongly coordinating phase-transfer organocatalysts, shuttling triazolate anions into solution. The intimate ion pairs formed in solution retain the reactivity of liberated triazole anions but, by virtue of highly regioselective ion pairing, exhibit alkylation selectivities that are completely inverted (1,2,4-triazole) or substantially enhanced (1,2,3-triazole) compared to the parent anions. The methodology allows direct access to 4-alkyl-1,2,4-triazoles (rr up to 94:6) and 1-alkyl-1,2,3-triazoles (rr up to 99:1) in one step. Regioselective ion pairing acts in effect as a noncovalent in situ protection mechanism, a concept that may have broader application in the control of ambident systems.

PURE INTERMEDIATE

-

Page/Page column 40, (2012/03/26)

The present invention relates to an improved process for the preparation of Letrozole (I) and its synthetic intermediate 4-[(1-(1,2,4-triazolyl)methyl]benzonitrile (III). In particular, it relates to a process to prepare Letrozole and its intermediate (III) substantially free from regioisomeric impurities. The present invention further relates to acid addition salts of 4-[(1-(1,2,4-triazolyl)methyl]benzonitrile (III) such as the oxalate salt, and also to Letrozole (I), the intermediate (III) and salts thereof preparable by the processes of the present invention.

Process for the Preparation of Letrozole

-

Page/Page column 6, (2010/08/07)

The present invention relates to the process for the preparation of Letrozole free from its regioisomer (7) and other impurities by selective extraction of desired intermediate (3) using suitable solvent and mixture of solvents.

Process for the preparation of letrozole

-

Page/Page column 6-7; 9, (2010/11/26)

The invention provides a high-yield process for the preparation of letrozole having a high purity, without the need for removal of the 4-[1-(1,3,4-triazolyl)methyl]benzonitrile impurity at the intermediate stage. The invention also provides a process for the synthesis of letrozole in which formation of the impurity 4-[1-(1,3,4-triazolyl)methyl]benzonitrile during the first stage is minimized. In the process, a 4-(halomethyl)benzonitrile is reacted with a salt of 1H-1,2,4-triazole, reducing the formation of the impurity. Preferably, the preparation is conducted as a one-pot process.

PROCESS FOR THE PREPARATION OF LETROZOLE

-

Page/Page column 2; 4; 5; 10-11, (2008/06/13)

The present invention relates to the process for the preparation of Letrozole free from its regioisomer (7) and other impurities by selective extraction of desired intermediate (3) using suitable solvent and mixture of solvents.

A METHOD FOR THE SEPARATION OF THE LETROZOLE PRECURSOR 4-‘1-(1,2,4-TRIAZOLYL) METHYL!BENZONITRILE FROM ITS 1,3,4-TRIAZOLYL ISOMER

-

Page/Page column 7-8, (2008/06/13)

A chemical method for the separation of letrozole precursor 4-[1-1,2,4-triazolyl)methyl]benzonitrile of formula (I) from the isomeric unwanted byproduct 4-[1-(1,3,4-triazolyl)methyl]benzonitrile of formula (II) of the reaction in which it is produced, which comprises (a) Preparing an isomeric mixtures of the compounds of formula (I) and (II) by conventional methods. (b) Dissolving the resultant crude isomeric mixture in dichloro methane (or) chloroform. (c) Adding 10-14% isopropylalcohol hydrochloride (IPACHI) to the resulting solution. (d) Adding isopropyl ether to precipitate undesired isomer is hydrochloride form. (e) Filtering off the undesired isomer hydrochloride. (f) Distilling off the filtrate completely. (g) Adding dilute sodium hydroxide solution and dichloromethane to the residue to liberate required isomer base of the formula (I). (h) Evaporating the separated dichloromethane layer and charging hexane or petroleum ether. (i) Centrifuging the resultant product of the formula (I) and washing with hexane or petroleum ether.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 112809-27-5